Rodriguez, PhD MPH Truveta, Inc , Bellevue, WA, Samuel Gratzl PhD Truveta, Inc , Bellevue, WA, Charlotte Baker DrPH MPH CPH Truveta, Inc , Bellevue, WA, Christopher M
Beyond drug delivery, nanotechnology facilitates biomaterial-based immunotherapies that modulate immune responses, targeting innate and adaptive immune cells to restore immune balance (7)
DupiIumab is licensed for the treatment of adults and children aged 12-17 with moderate to severe atopic eczema and children with severe atopic eczema aged between 6 months and 11 years, who would otherwise be possible candidates for systemic immunosuppressive drugs
To me, sticking our heads in the sand and ignoring this conversation is like preaching abstinence as the only form of contraception on a college campuslargely ineffective